New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Goodness Growth Holdings, Inc.
GDNSF
Shape
US Flag

PNK

Unprofitable

Unprofitable

61M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

61M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.45USD
Shape0.00 ( 0.02%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-50%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated October 16, 2024
1W % 1M % 3M 8.51 % 1Y 198.25 %

Key Metrics

Shape
  • Market Cap

    61.05M


  • Shares Outstanding

    135.00M


  • Share in Float


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.4522


  • Average Volume

    142782


  • Beta

    1.419


  • Range

    0.0901-0.68


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.goodnessgrowth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.66x

P/S Ratio

-2.87x

P/B Ratio

-3.2

Debt/Equity

-25.6%

Net Margin

$-0.2

EPS

How GDNSF compares to sector?

P/E Ratio

Relative Strength

Shape

GDNSF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$96M

Shape302%

2024-Revenue

$0.12

Shape-157%

2024-EPS

$22M

Shape-536%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.04
vs -0.04

Q3.22

arrow
arrow

N/A

-0.07
vs -0.04

Q4.22

arrow
arrow

N/A

-0.10
vs -0.10

Q1.23

arrow
arrow

N/A

-0.07
vs -0.08

Q2.23

arrow
arrow

N/A

-0.06
vs -0.04

Q3.23

arrow
arrow

N/A

-0.04
vs -0.07

Q4.23

arrow
arrow

N/A

-0.03
vs -0.10

Q1.24

arrow
arrow

N/A

-0.05
vs -0.07

Q3.24

arrow
arrow

N/A

-0.03
vs -0.04

Q4.24

arrow
arrow

N/A

-0.02
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+48%

21.1M  vs 14.2M

Q3.22

arrow
arrow

+41%

18.9M  vs 13.4M

Q4.22

arrow
arrow

+39%

19M  vs 13.7M

Q1.23

arrow
arrow

+22%

19.1M  vs 15.6M

Q2.23

arrow
arrow

-4%

20.2M  vs 21.1M

Q3.23

arrow
arrow

+31%

24.7M  vs 18.9M

Q4.23

arrow
arrow

+27%

24.2M  vs 19M

Q1.24

arrow
arrow

+26%

24M  vs 19.1M

Q3.24

arrow
arrow

-2%

24.1M  vs 24.7M

Q4.24

arrow
arrow

+0%

24.2M  vs 24.2M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-26%

-0.26
vs -0.50

Q3.22

arrow
arrow

-51%

-0.51
vs -0.26

Q4.22

arrow
arrow

-386%

-3.86
vs -0.51

Q1.23

arrow
arrow

+407%

4.07
vs -3.86

Q2.23

arrow
arrow

+92%

0.92
vs 4.07

Q3.23

arrow
arrow

+41%

0.41
vs 0.92

Q4.23

arrow
arrow

+29%

0.29
vs 0.41

Q1.24

arrow
arrow

+30%

0.3
vs 0.29

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

3

3
vs NA

NA

Q3.21

arrow
arrow

1

1
vs 3

-67%

Q4.21

arrow
arrow

2

2
vs 1

100%

Q1.22

arrow
arrow

2

2
vs 2

NA

Q2.22

arrow
arrow

2

2
vs 2

NA

Q3.22

arrow
arrow

1

1
vs 2

-50%

Q4.22

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News